Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review

Sarcomas are a diverse group of neoplasms with an incidence rate of 15% of childhood cancers. They exhibit a high tendency to develop early metastases and are often resistant to available treatments, resulting in poor prognosis and survival. In this context, cancer stem cells (CSCs) have been implic...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 15; no. 9; p. 2449
Main Authors Chico, Maria Angeles, Mesas, Cristina, Doello, Kevin, Quiñonero, Francisco, Perazzoli, Gloria, Ortiz, Raul, Prados, Jose, Melguizo, Consolacion
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 25.04.2023
MDPI
Subjects
Analysis
Bibliographic literature
Biomarkers
Bone cancer
Cancer
cancer stem cells
Care and treatment
Chemotherapy
Children
Development and progression
Drug resistance
Fibrosarcoma
Liposarcoma
Medical prognosis
Medical Subject Headings-MeSH
Metastases
Metastasis
Precision medicine
Prognosis
Review
Sarcoma
sarcomas
Stem cells
Systematic review
cancer stem cells
drug resistance
sarcomas
systematic review
biomarkers
Online AccessGet full text

Cover

More Information
Summary:Sarcomas are a diverse group of neoplasms with an incidence rate of 15% of childhood cancers. They exhibit a high tendency to develop early metastases and are often resistant to available treatments, resulting in poor prognosis and survival. In this context, cancer stem cells (CSCs) have been implicated in recurrence, metastasis, and drug resistance, making the search for diagnostic and prognostic biomarkers of the disease crucial. The objective of this systematic review was to analyze the expression of CSC biomarkers both after isolation from in vitro cell lines and from the complete cell population of patient tumor samples. A total of 228 publications from January 2011 to June 2021 was retrieved from different databases, of which 35 articles were included for analysis. The studies demonstrated significant heterogeneity in both the markers detected and the CSC isolation techniques used. ALDH was identified as a common marker in various types of sarcomas. In conclusion, the identification of CSC markers in sarcomas may facilitate the development of personalized medicine and improve treatment outcomes.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers15092449